{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T12:26:02Z","timestamp":1708518362269},"reference-count":41,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2017.0168","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:29:13Z","timestamp":1525253353000},"source":"Crossref","is-referenced-by-count":5,"title":["Mental Disorders in People Affected by Thalidomide"],"prefix":"10.3238","author":[{"given":"Alexander","family":"Niecke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Samel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Forster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"L\u00fcngen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Pfaff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Albus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2017,3,10]]},"reference":[{"key":"10.3238\/arztebl.2017.0168_ref1","unstructured":"Kirk B: Der Contergan-Fall: eine unvermeidliche Katastrophe? Zur Geschichte des Arzneistoffs Thalidomid. Stuttgart: Greifswalder Schriften zur Geschichte der Pharmazie und Sozialpharmazie 1999."},{"key":"10.3238\/arztebl.2017.0168_ref2","unstructured":"Sj\u00f6str\u00f6m H, Nilsson R: Thalidomide and the power of the drug companies. Harmondsworth: Penguin 1972."},{"key":"10.3238\/arztebl.2017.0168_ref3","unstructured":"Knightley P, Evans H, Potter E, Wallace M: Suffer the children: the story of thalidomide. London: Andr\u00e9 Deutsch Limited 1979."},{"key":"10.3238\/arztebl.2017.0168_ref4","doi-asserted-by":"crossref","unstructured":"Lenz W: A short history of thalidomide embryopathy. Teratology 1988; 38: 203\u201315","DOI":"10.1002\/tera.1420380303"},{"key":"10.3238\/arztebl.2017.0168_ref5","unstructured":"Stephens T, Brynner R: Dark remedy. The impact of thalidomide and its revival as a vital medicine. Cambridge, Massachusetts: Perseus publishing 2001."},{"key":"10.3238\/arztebl.2017.0168_ref6","doi-asserted-by":"crossref","unstructured":"Franks ME, McPherson GR, Figg WD: Thalidomide. Lancet 2004; 363: 1802\u201311","DOI":"10.1016\/S0140-6736(04)16308-3"},{"key":"10.3238\/arztebl.2017.0168_ref7","unstructured":"Friedrich C: Contergan \u2013 zur Geschichte einer Arzneimittelkatastrophe. In: Zichner L, Rauschmann MA, Thomann KD (eds.): Die Contergankatastrophe \u2013 Eine Bilanz nach 40 Jahren. Darmstadt: Steinkopff 2005; 3\u201312"},{"key":"10.3238\/arztebl.2017.0168_ref8","unstructured":"Thomann KD: Die Contergan-Katastrophe: Die tr\u00fcgerische Sicherheit der \u201eharten\u201c Daten. Dtsch Arztebl 2007; 104: A2778\u20138"},{"key":"10.3238\/arztebl.2017.0168_ref9","doi-asserted-by":"crossref","unstructured":"McBride WG: Thalidomide and congenital abnormalities. Letter to the editor. Lancet 1961; 44: 1358","DOI":"10.1016\/S0140-6736(61)90927-8"},{"key":"10.3238\/arztebl.2017.0168_ref10","doi-asserted-by":"crossref","unstructured":"Lenz W: Kindliche Missbildungen nach Medikamenteneinnahme w\u00e4hrend der Gravidit\u00e4t? Dtsch Med Wochenschr 1961; 52: 2555\u20136.","DOI":"10.1055\/s-0032-1329408"},{"key":"10.3238\/arztebl.2017.0168_ref11","doi-asserted-by":"crossref","unstructured":"Dally A: Thalidomide: Was the tragedy preventable? Lancet 1998; 351: 1197\u20139","DOI":"10.1016\/S0140-6736(97)09038-7"},{"key":"10.3238\/arztebl.2017.0168_ref12","doi-asserted-by":"crossref","unstructured":"Emanuel M, Rawlins M, Duff G, Breckenridge A: Thalidomide and its sequelae. Lancet 2012; 9844: 781\u20133","DOI":"10.1016\/S0140-6736(12)60468-1"},{"key":"10.3238\/arztebl.2017.0168_ref13","doi-asserted-by":"crossref","unstructured":"Annas GJ, Elias S: Thalidomide and the titanic: Reconstructing the technology tragedies of the twentieth century. Am J Pub Health 1999; 89: 98\u2013101","DOI":"10.2105\/AJPH.89.1.98"},{"key":"10.3238\/arztebl.2017.0168_ref14","doi-asserted-by":"crossref","unstructured":"Maio G: Ethische \u00dcberlegungen zur Contergankatastrophe. In: Zichner L, Rauschmann MA, Thomann KD (eds.): Die Contergankatastrophe \u2013 Eine Bilanz nach 40 Jahren. Darmstadt: Steinkopff 2005; 129\u201333","DOI":"10.1007\/3-7985-1585-9_14"},{"key":"10.3238\/arztebl.2017.0168_ref15","doi-asserted-by":"crossref","unstructured":"Kim JH, Scialli R: Thalidomide: The tragedy of birth defects and the effective treatment of disease. Toxicol Sci 2011; 122: 1\u20136","DOI":"10.1093\/toxsci\/kfr088"},{"key":"10.3238\/arztebl.2017.0168_ref16","doi-asserted-by":"crossref","unstructured":"Rocha J: Thalidomide given to women in Brazil. BMJ 1994; 308: 1061","DOI":"10.1136\/bmj.308.6936.1061a"},{"key":"10.3238\/arztebl.2017.0168_ref17","doi-asserted-by":"crossref","unstructured":"Schuler-Faccini L, Soares RC, de Sousa AC, et al.: New cases of thalidomide embryopathy in Brazil. Birth Defects Res A Clin Teratol 2007; 79: 671\u20132","DOI":"10.1002\/bdra.20384"},{"key":"10.3238\/arztebl.2017.0168_ref18","unstructured":"Bundesverband Contergangesch\u00e4digter e. V.: www.contergan.de (last accessed on 28 June 2016)."},{"key":"10.3238\/arztebl.2017.0168_ref19","doi-asserted-by":"crossref","unstructured":"Peters KM: Thalidomid-Embryopathie: Eine vielf\u00e4ltige Katastrophe. Orthop\u00e4die & Rheuma 2012; 15: 23\u20138","DOI":"10.1007\/s15002-012-0064-2"},{"key":"10.3238\/arztebl.2017.0168_ref20","unstructured":"Kruse A, Ding-Greiner C, Becker G, Stolla C, Becker AM, Baiker D: Contergan \u2013 Wiederholt durchzuf\u00fchrende Befragungen zu Problemen, speziellen Bedarfen und Versorgungsdefiziten von contergangesch\u00e4digten Menschen. Endbericht an die Conterganstiftung f\u00fcr behinderte Menschen. Heidelberg 2012."},{"key":"10.3238\/arztebl.2017.0168_ref21","unstructured":"Kennelly C, Kelson M, Riesel J: Thalidomide impaired people: quality of life. Report of a community fund project on behalf of the thalidomide society. College of Health and the Thalidomide Society 2002."},{"key":"10.3238\/arztebl.2017.0168_ref22","doi-asserted-by":"crossref","unstructured":"Nippert I, Edler B, Schmidt-Herterich C: 40 years later: The health related quality of life of woman affected with thalidomide. Community Genet 2002; 5: 209\u201316","DOI":"10.1159\/000066691"},{"key":"10.3238\/arztebl.2017.0168_ref23","doi-asserted-by":"crossref","unstructured":"Bent N, Tennant A, Neumann V, Chamberlain MA: Living with thalidomide: Health status and quality of life at 40 years. Prosthet Orthot Int 2007; 31: 147\u201356","DOI":"10.1080\/03093640600988567"},{"key":"10.3238\/arztebl.2017.0168_ref24","doi-asserted-by":"crossref","unstructured":"Enns M, Rester D, Seeberger B: Studien\u00fcberblick zur Lebenssituation \u00e4lter werdender Contergan-gesch\u00e4digter Menschen. Heilberufe Science 2009; 2: 35\u201340","DOI":"10.1007\/s00058-009-1412-8"},{"key":"10.3238\/arztebl.2017.0168_ref25","doi-asserted-by":"crossref","unstructured":"O\u2018Carroll A, O\u2018Reilly F, Whitford DL: What has happened to people affected by thalidomide 50 years on? Ir J Med Sci 2011; 180: 475\u20138","DOI":"10.1007\/s11845-011-0683-7"},{"key":"10.3238\/arztebl.2017.0168_ref26","doi-asserted-by":"crossref","unstructured":"Imai K, Iida T, Yamamoto M, Komatsu K, Nukui Y, Yoshizawa A: Psychological and mental health problems in patients with thalidomide embryopathy in Japan. Psychiatry Clin Neurosci 2014; 68: 479\u201386","DOI":"10.1111\/pcn.12152"},{"key":"10.3238\/arztebl.2017.0168_ref27","doi-asserted-by":"crossref","unstructured":"Ornoy A, Weinstein-Fudim L, Ergaz Z: Prenatal factors associated with autism spectrum disorder (ASD). Reprod Toxicol 2015; 56: 155\u201369","DOI":"10.1016\/j.reprotox.2015.05.007"},{"key":"10.3238\/arztebl.2017.0168_ref28","doi-asserted-by":"crossref","unstructured":"Kowalski TW, Sanseverino MT, Schuler-Faccini L, Vianna FS: Thalidomide embryopathy: follow-up of cases born between 1959 and 2010. Birth Defects Res A Clin Mol Teratol 2015; 103: 794\u2013803","DOI":"10.1002\/bdra.23376"},{"key":"10.3238\/arztebl.2017.0168_ref29","unstructured":"Wittchen HU, Zaudig M, Fydrich T: Strukturiertes klinisches Interview f\u00fcr DSM-IV (SKID-I und SKID-II). G\u00f6ttingen: Hogrefe 1997."},{"key":"10.3238\/arztebl.2017.0168_ref30","unstructured":"Grauber B: ICD-10-GM 2016. Systematisches Verzeichnis. Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme. 10. Revision \u2013 German Modification Version 2016. K\u00f6ln: Deutscher \u00c4rzteverlag 2016."},{"key":"10.3238\/arztebl.2017.0168_ref31","doi-asserted-by":"crossref","unstructured":"Jacobi F, Wittchen HU, Holting C, et al.: Prevalence, comorbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med 2004; 34: 597\u2013611","DOI":"10.1017\/S0033291703001399"},{"key":"10.3238\/arztebl.2017.0168_ref32","unstructured":"Mikrozensus 2011: Haushalte und Lebensformen der Bev\u00f6lkerung. Wiesbaden: Statistisches Bundesamt 2012."},{"key":"10.3238\/arztebl.2017.0168_ref33","doi-asserted-by":"crossref","unstructured":"Jacobi F, Mack S, Gerschler A, et al.: The design and methods of the mental health module in the German Health Interview and Examination Survey for Adults (DEGS1-MH). Int J Methods Psychiatr Res 2013; 22: 83\u201399","DOI":"10.1002\/mpr.1387"},{"key":"10.3238\/arztebl.2017.0168_ref34","doi-asserted-by":"crossref","unstructured":"Jacobi F, H\u00f6fler M, Siegert J, et al.: Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the mental health module of the German Health Interview and Examination Survey for Adults (DEGS1-MH). Int J Methods Psychiatr Res 2014; 23: 304\u201319","DOI":"10.1002\/mpr.1439"},{"key":"10.3238\/arztebl.2017.0168_ref35","doi-asserted-by":"crossref","unstructured":"Gili M, Comas A, Garcia-Garcia M, Monz\u00f3n S, Antoni SB, Roca B: Comorbidity between common mental disorders and chronic somatic diseases in primary care patients. Gen Hosp Psychiatry 2010; 32: 240\u20135","DOI":"10.1016\/j.genhosppsych.2010.01.013"},{"key":"10.3238\/arztebl.2017.0168_ref36","doi-asserted-by":"crossref","unstructured":"H\u00e4rter M, Baumeister H, Reuter K, et al.: Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychother Psychosom 2007; 76: 354\u201360","DOI":"10.1159\/000107563"},{"key":"10.3238\/arztebl.2017.0168_ref37","doi-asserted-by":"crossref","unstructured":"Turner RJ, Lloyd DA, Taylor J: Physical disability and mental health: An epidemiology of psychiatric and substance disorders. Rehabil Psychol 2006; 51: 214\u201323","DOI":"10.1037\/0090-5550.51.3.214"},{"key":"10.3238\/arztebl.2017.0168_ref38","unstructured":"DGPPN, B\u00c4K, KBV, et al. f\u00fcr die Leitliniengruppe Unipolare Depression: S3-Leitlinie\/Nationale VersorgungsLeitlinie Unipolare Depression. 2nd edition. 2015. www.depression.versorgungsleitlinien.de (last accessed on 28 February 2016)."},{"key":"10.3238\/arztebl.2017.0168_ref39","doi-asserted-by":"crossref","unstructured":"Keitner GI, Ryan CE, Miller IW, Norman WH: Recovery and major depression: factors associated with twelve-month outcome. Am J Psychiatry 1992; 149: 93\u20139","DOI":"10.1176\/ajp.149.1.93"},{"key":"10.3238\/arztebl.2017.0168_ref40","doi-asserted-by":"crossref","unstructured":"Wittchen HU, Jacobi F: Die Versorgungssituation psychischer St\u00f6rungen in Deutschland. Eine klinisch-epidemiologische Absch\u00e4tzung anhand des Bundes-Gesundheitssurveys 1998. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2001; 44: 993\u20131002","DOI":"10.1007\/s001030100269"},{"key":"10.3238\/arztebl.2017.0168_ref41","unstructured":"Altman D, Machin D, Bryant T, Gardner M: Statistics with confidence: Confidence intervals and statistical guidelines. 2nd\u00a0revision. London: BMJ Books 2000."}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2017.0168","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T10:15:28Z","timestamp":1638872128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2017.0168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,10]]},"references-count":41,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2017.0168","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,10]]}}}